Nanotechnological approaches for the delivery of macromolecules

Journal of Controlled Release

Volumn 87, Issue 1-3, 2003, Pages 81-88

  Crommelin, Daan J A ^a,b   Storm, Gert ^a   Jiskoot, Wim ^a   Stenekes, Robert ^a,c   Mastrobattista, Enrico ^a,d   Hennink, Wim E ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b OctoPlus NV   (Netherlands)

^c Polymer Service Centre Groningen   (Netherlands)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Drug targeting; Lipoplexes; Liposomes; Nanotechnology; Polymers; Polyplexes

Indexed keywords

DEXTRAN; DNA; LIPOSOME; PHOSPHOLIPID; POLYMER; PROTEIN;

BIODEGRADABILITY; CONFERENCE PAPER; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; GENETIC TRANSFECTION; HYDROGEL; MACROMOLECULE; PLASMID; PRIORITY JOURNAL;

EID: 0037458999     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00014-2     Document Type: Conference Paper

References (17)

1. Van de Weert M., van't Hof R., Van der Weerd J., Heeren R.M., Posthuma G., Hennink W.E., Crommelin D.J.A. Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. J. Control. Release. 68:2000;31-40.
2. Van de Weert M., Hennink W.E., Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm. Res. 17:2000;1159-1167.
3. Bos G.W., Verrijk R., Franssen O., Bezemer J., Hennink W.E., Crommelin D.J.A. Hydrogels for controlled release of pharmaceutical proteins. Biopharm. Europe. 13:(11):2001;64-74.
4. Van Nostrum C.F., Hennink W.E. Novel cross-linking methods to design hydrogels. Adv. Drug Deliv. Rev. 54:2002;13-36.
5. Van Dijk-Wolthuis W.N.E., Hoogeboom J.A.M., Van Steenbergen M.J., Tsang S.K.Y., Hennink W.E. Degradation and release behavior of dextran-based hydrogels. Macromolecules. 30:1997;4639-4645.
6. Stenekes R.J.H., Franssen O., Van Bommel E.M.G., Crommelin D.J.A., Hennink W.E. The preparation of dextran microspheres in an all-aqueous system: effect of the formulation parameters on particle characteristics. Pharm. Res. 15:1998;557-561.
7. De Jong S.J., De Smedt S.C., Demeester J., van Nostrum C.F., Kettenes-van den Bosch J.J., Hennink W.E. Biodegradable hydrogels based on stereocomplex formation between lactic acid oligomers grafted to dextran. J. Control. Release. 72:(1-3):2001;47-56.
8. Franssen O., Vandervennet L., Roders P., Hennink W.E. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres. J. Control. Release. 60:1999;211-221.
9. Cadée J.A., Van Steenbergen M.J., Versluis C., Heck A.J.R., Underberg W.J.M., Den Otter W., Jiskoot W., Hennink W.E. Oxidation of recombinant human interleukin-2 by potassium peroxodisulfate. Pharm. Res. 18:2001;1461-1467.
10. Cadée J.A., de Groot C.J., Jiskoot W., den Otter W., Hennink W.E. Release of recombinant human interleukin-2 from dextran-based hydrogels. J. Control. Release. 78:2002;1-13.
11. Stenekes R.J.H., Hennink W.E. Polymerization kinetics of dextran-bound methacrylate in an aqueous two-phase system. Polymer. 41:2000;5563-5569.
12. Stenekes R.J.H., de Smedt S.C., Demeester J., Sun G., Zhang Z., Hennink W.E. Pore sizes in hydrated dextran microspheres. Biomacromolecules. 1:2000;696-703.
13. Cadée J.A., Van Luyn M.J., Brouwer L.A., Plantinga J.A., Van Wachem P.B., De Groot C.J., Den Otter W., Hennink W.E. In vivo biocompatibility of dextran-based hydrogels. J. Biomed. Mater. Res. 50:2000;397-404.
14. Stenekes R.J.H., Loebis A.E., Fernandes C.M., Crommelin D.J.A., Hennink W.E. Controlled release of liposomes from biodegradable dextran microspheres: a novel delivery concept. Pharm. Res. 17:2000;690-695.
15. Nässander U.K., Steerenberg P.A., Poppe H., Storm G., Jap P.H.K., Poels L.G., de Jong W.H., Crommelin D.J.A. In vivo targeting of OV-TL3 immunoliposomes to ovarian carcinoma ascitic cells (OVCAR-3) in athymic nude mice. Cancer Res. 52:1992;646-653.
16. Mastrobattista E., Kapel R.H.G., Eggenhuizen M.H., Roholl P.J.M., Crommelin D.J.A., Hennink W.E., Storm G. Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells. Cancer Gene Ther. 8:2001;405-413.
17. E. Mastrobattista, Targeted liposomes for cytosolic drug delivery to tumor cells, Thesis, 2001.